“Unfortunately, pancreatic cancer remains a very difficult disease to treat. Although we’ve made progress over the past several years, it has been very incremental. We have broadened our cytotoxic armamentarium, and for the first time, we’ve been able to tailor therapy based on the genetic profile of the tumor itself,” said Iqbal. Read more . . .
Although pancreatic cancer has been a historically difficult disease to treat, the emergence of novel combinations have allowed for more patients to receive later lines of therapy, and recent advances have inspired a shift to more personalized treatment approaches to improve outcomes, according to Syma Iqbal, MD.